Element Raises $30M in Additional Series B Financing to Accelerate Development of a New Sequencing Platform

June 26, 2020

SAN DIEGO, Calif. — Element Biosciences raised an additional $30M in Series B financing, with participation from new investors RA Capital Advisors and Alexandria Venture Investments. Proceeds from the financing will be used to accelerate the development of a new DNA sequencing platform. To date, the company has raised a total of more than $130M.

© 2020 Element Biosciences, Inc. All rights reserved.